PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Eisai makes lecanemab therapy application

Treatment involves early Alzheimer’s disease and will be potentially used across Great Britain. Eisai has submitted a Marketing Authorisation Application (MAA) fo...
Continue Reading →
News

Vital patent for AlzeCure Alzheimer’s drug

ACD856 is the leading candidate therapy on the company’s NeuroRestore platform. AlzeCure – a company that focuses on developing Alzheimer's disease treatments – h...
Continue Reading →
News

AstraZeneca’s dapagliflozin recommended by NICE

Treatment concerns up to 150,000 patients in England with chronic heart failure. The National Institute for Health and Care Excellence (NICE) has issued final dra...
Continue Reading →
News

Connect in Pharma launches partnerships for global health innovation

Sciad Newswire / Connect in Pharma announce today that for every visitor to the 2023 Geneva-based event, five Swiss francs will be donated to Global Health Security ...
Continue Reading →
News

FDA says no to Byondis breast cancer ADC

Dutch biopharma Byondis announced that the U.S. FDA issued a complete response letter for the company's lead asset, an anti-HER2 antibody-drug conjugate (ADC) for br...
Continue Reading →
News

Robotic platform R-One launched by Robocath

The solution allows a cardiologist to perform coronary angioplasties using an integrated control command unit. Robocath – a company that focuses on robotic soluti...
Continue Reading →
News

Approval provided for Angelini’s cenobamate

Treatment will now be used across Ireland among adults with focal onset seizures with epilepsy. Angelini Pharma has revealed that cenobamate has been reimbursed f...
Continue Reading →
News

Positive data for Acesion’s atrial fibrillation candidates

The company intends to advance AF drugs that address current risk concerns with existing therapies. Acesion Pharma – a company focusing on atrial fibrillation (AF...
Continue Reading →
News

Integrated pathology unit to focus on novel technology

The first unit of its kind in England will identify biomarkers and diagnose cancer much faster. The Institute of Cancer Research (ICR) and the Royal Marsden NHS F...
Continue Reading →
News

L.B. Bohle presents world novelties at Interpack

State-of-the-art technology " packed" in a modern way For more than four decades, L.B. Bohle has stood for cutting-edge technology in the pharmaceutical industry....
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026